Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy. (2021)
Attributed to:
Evaluation of the CD4+ T cell tumour microenvironment of low grade B cell lymphoproliferative disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood.2020006073
PubMed Identifier: 33024998
Publication URI: http://europepmc.org/abstract/MED/33024998
Type: Journal Article/Review
Volume: 137
Parent Publication: Blood
Issue: 2
ISSN: 0006-4971